Want to see HK:8156 full AI Analyst Report?
Sinopharm Tech Holdings Limited (8156) Ratios
Sinopharm Tech Holdings Limited Ratios
HK:8156's free cash flow for Q3 2025 was $-3.00M. For the 2025 fiscal year, HK:8156's free cash flow was increased by $0.00 and operating cash flow was $-3.00M. See a summary of the company’s cash flow.
| Ratios | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.38 | 0.72 | 0.15 | 0.13 | 0.19 |
| Quick Ratio | 0.38 | 0.52 | 0.14 | 0.12 | 0.19 |
| Cash Ratio | 0.10 | 0.10 | 0.01 | 0.01 | 0.01 |
| Solvency Ratio | -0.11 | 0.01 | -0.07 | -0.04 | -0.34 |
| Operating Cash Flow Ratio | -0.07 | -0.11 | -0.04 | 0.02 | -0.15 |
| Short-Term Operating Cash Flow Coverage | -0.27 | -0.27 | -0.13 | 0.09 | -0.82 |
| Net Current Asset Value | $ -50.35M | $ -39.30M | $ -212.02M | $ -186.19M | $ -202.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.37 | 0.90 | 1.65 | 1.58 | 0.60 |
| Debt-to-Equity Ratio | -0.66 | -1.27 | -0.37 | -0.31 | -0.28 |
| Debt-to-Capital Ratio | -1.96 | 4.74 | -0.58 | -0.44 | -0.38 |
| Long-Term Debt-to-Capital Ratio | -0.52 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.48 | -1.40 | -0.22 | -0.19 | -0.46 |
| Debt Service Coverage Ratio | -0.48 | 0.18 | 0.05 | 0.00 | -1.22 |
| Interest Coverage Ratio | 0.00 | -1.22 | -0.38 | -10.59 | -3.54 |
| Debt to Market Cap | 0.33 | 0.31 | 3.56 | 0.83 | 0.08 |
| Interest Debt Per Share | 0.07 | 0.11 | 0.53 | 0.34 | 0.35 |
| Net Debt to EBITDA | -3.62 | 6.51 | 14.18 | -50.46 | -0.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.09% | 22.06% | 12.16% | 12.77% | 12.44% |
| EBIT Margin | -17.91% | 7.80% | 8.72% | -7.05% | -189.70% |
| EBITDA Margin | -15.22% | 9.97% | 12.06% | -2.37% | -183.41% |
| Operating Profit Margin | -17.91% | -11.64% | -22.20% | -211.91% | -141.56% |
| Pretax Profit Margin | -25.65% | -1.76% | -49.26% | -25.33% | -229.74% |
| Net Profit Margin | -20.06% | -1.42% | -47.72% | -24.83% | -214.71% |
| Continuous Operations Profit Margin | -26.11% | -2.24% | -49.46% | -22.27% | -228.79% |
| Net Income Per EBT | 78.20% | 80.35% | 96.88% | 98.03% | 93.46% |
| EBT Per EBIT | 143.15% | 15.14% | 221.89% | 11.95% | 162.29% |
| Return on Assets (ROA) | -40.74% | -1.68% | -44.28% | -31.76% | -114.45% |
| Return on Equity (ROE) | 19.70% | 2.35% | 9.87% | 6.16% | 52.76% |
| Return on Capital Employed (ROCE) | 24.78% | 42.84% | 4.47% | 50.50% | 33.46% |
| Return on Invested Capital (ROIC) | 44.99% | -71.00% | 6.92% | 62.99% | 45.33% |
| Return on Tangible Assets | -40.74% | -1.68% | -44.28% | -31.76% | -114.45% |
| Earnings Yield | -9.70% | -1.01% | -97.48% | -16.62% | -16.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.98 | 2.32 | 1.45 | 1.87 | 0.97 |
| Payables Turnover | 4.27 | 2.08 | 1.12 | 1.07 | 0.64 |
| Inventory Turnover | 331.87 | 3.54 | 10.25 | 43.71 | 51.40 |
| Fixed Asset Turnover | 30.92 | 23.53 | 10.63 | 36.83 | 7.90 |
| Asset Turnover | 2.03 | 1.18 | 0.93 | 1.28 | 0.53 |
| Working Capital Turnover Ratio | -1.70 | -0.53 | -0.21 | -0.22 | -0.19 |
| Cash Conversion Cycle | -38.54 | 85.21 | -38.99 | -137.49 | -183.59 |
| Days of Sales Outstanding | 45.76 | 157.56 | 252.51 | 195.35 | 377.74 |
| Days of Inventory Outstanding | 1.10 | 103.07 | 35.61 | 8.35 | 7.10 |
| Days of Payables Outstanding | 85.40 | 175.43 | 327.11 | 341.20 | 568.42 |
| Operating Cycle | 46.86 | 260.63 | 288.12 | 203.70 | 384.84 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.05 | 0.03 | -0.20 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.07 | 0.03 | -0.21 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -2.78 | 0.00 | -303.83 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -2.78 | 0.00 | -303.83 |
| Operating Cash Flow Coverage Ratio | -0.13 | -0.15 | -0.13 | 0.09 | -0.80 |
| Operating Cash Flow to Sales Ratio | -0.09 | -0.12 | -0.22 | 0.11 | -0.90 |
| Free Cash Flow Yield | -4.27% | -8.38% | -62.26% | 7.39% | -6.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.30 | -97.37 | -1.03 | -6.02 | -6.13 |
| Price-to-Sales (P/S) Ratio | 2.07 | 1.40 | 0.49 | 1.49 | 13.17 |
| Price-to-Book (P/B) Ratio | -2.03 | -2.33 | -0.10 | -0.37 | -3.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -23.42 | -11.93 | -1.61 | 13.52 | -14.63 |
| Price-to-Operating Cash Flow Ratio | -23.42 | -11.93 | -2.18 | 13.52 | -14.68 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.99 | -0.01 | 0.07 | 0.29 |
| Enterprise Value Multiple | -17.20 | 20.59 | 18.24 | -113.52 | -7.75 |
| Enterprise Value | 119.32M | 125.77M | 90.82M | 115.23M | 582.58M |
| EV to EBITDA | -17.20 | 20.59 | 18.24 | -113.52 | -7.75 |
| EV to Sales | 2.62 | 2.05 | 2.20 | 2.69 | 14.21 |
| EV to Free Cash Flow | -29.67 | -17.45 | -7.22 | 24.35 | -15.79 |
| EV to Operating Cash Flow | -29.67 | -17.45 | -9.82 | 24.35 | -15.85 |
| Tangible Book Value Per Share | -0.11 | -0.08 | -1.12 | -0.98 | -0.96 |
| Shareholders’ Equity Per Share | -0.10 | -0.08 | -1.09 | -0.94 | -0.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | -0.27 | -0.00 | 0.12 | 0.00 |
| Revenue Per Share | 0.10 | 0.13 | 0.22 | 0.23 | 0.23 |
| Net Income Per Share | -0.02 | -0.00 | -0.11 | -0.06 | -0.49 |
| Tax Burden | 0.78 | 0.80 | 0.97 | 0.98 | 0.93 |
| Interest Burden | 1.43 | -0.23 | -5.65 | 3.59 | 1.21 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.32 | 0.34 | 0.33 | 0.46 | 1.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.02 | 0.06 | 0.11 |
| Income Quality | 0.44 | 8.31 | 0.46 | -0.41 | 0.39 |
Currency in HKD
